July 7, 2017
Evonik starts marketing GutCare® PY1 in India, Bangladesh
Evonik will now offer the probiotic GutCare® PY1 in India and Bangladesh following launches in the US and China earlier this year.
GutCare® PY1 has a positive effect on the healthy balance of bacteria populations in the chicken gut which has been scientifically proven by numerous studies for in vitro and in vivo cases.
GutCare® PY1 contains the spores of the strain Bacillus subtilis DSM 32315. "With our broad portfolio of amino acids and probiotics, we are able to fully support our customers on the road to sustainable animal nutrition targeting reduced use of antibiotics ", Dr. Emmanuel Auer, head of the Animal Nutrition business line at Evonik, said.
A healthy gut microbiome reduces the risk of inflammatory diseases that can lead to high costs in livestock production. Commonly caused by bacteria such as Clostridium perfringens, diseases are responsible for several billion US dollars of damage to the livestock industry annually.
Evonik had introduced GutCare® PY1 to the US market in January and to the Chinese market in April this year.
By the end of 2018, the company wants to be present in every Asian country with at least one probiotic.
For Evonik, GutCare® PY1 is the first probiotic from the company's own development. Since the acquisition of the probiotic business of the Spanish company NOREL S.A. in 2016, Evonik offers two probiotics: Ecobiol® (Bacillus amyloliquefaciens CECT 5940) and Fecinor® (Enterococcus faecium CECT 4515). In addition to product development, Evonik is also focusing on deciphering the mechanisms of the chicken gut.
The company's new simulation model had helped to describe the interactions between nutrition, the immune system and the intestinal microbiotia on July this year.
- Evonik
